2021-07-20

my country has developed the “universal artificial blood” closest to human natural red blood cells

By yqqlm yqqlm

The project has started to apply for Phase I clinical research, and it is expected to be marketed as a “breakthrough therapy drug” within 3-4 years.

my country has developed the “universal artificial blood” closest to human natural red blood cells

“Artificial blood” is blood oxygen fluid It is medically called human red blood cell substitute, which is a kind of “life-saving medicine” that can replace red blood cells in clinical practice and supply oxygen to ischemic tissues and organs in a timely manner.

Beginning in 2001, the R&D team carried out research on key scientific and technological strengths within the United Nations, breaking through the bottleneck that plagued the global “artificial blood” research and development, and successively overcame the effective oxygen release and vasoconstriction of similar products in the world. Technical difficulties, and built the only domestic pilot production line, established a stable, controllable and complete production process and quality control system.

Especially when the research of similar products in the world has almost stagnated, the project has received major special projects such as the national “863 Program”, major new drug creation, and key research and development programs, and has been supported by Shaanxi Province for many years.

my country has developed the “universal artificial blood” closest to human natural red blood cells(1)

The team also simulated clinical operations, accidents and For emergency treatment of massive hemorrhage at the disaster site, the Institute of Military Medicine of the Academy of Military Sciences, West China Hospital of Sichuan University and other units have established rat, dog, monkey and other related animal models, confirming that the product can completely replace red blood cells for emergency blood transfusion and save lives.

And, as a kind of “universal blood”, it can be used by people of any blood type, and has the advantages of on-demand use, no risk of virus infection, and effective storage period of more than 1 year.

It is worth mentioning that the team has mastered all core technologies and has completely independent intellectual property rights. It has established patent clusters including hemoglobin purification, virus inactivation, polymerization technology, reduction technology, storage technology, etc. The key technology has been Obtained 17 national invention patents.